Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.1186/s12863-024-01286-y
Published Online: 2024-12-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mahajan, Rashmi
Tyagi, Anuj Kumar
Text and Data Mining valid from 2024-12-05
Version of Record valid from 2024-12-05
Article History
Received: 3 September 2024
Accepted: 26 November 2024
First Online: 5 December 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.